Evidence map›Paper›PMID 40858574›Full record

ArticleNature communications2025

Predictive design of crystallographic chiral separation.

Rokas Elijošius, Emma King-Smith, Felix A Faber, Louise Bernier, Simon Berritt, William P Farrell, Xinjun Hou, Jacquelyn L Klug-McLeod, Jason Mustakis, Neal W Sach and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rokas ElijošiusDepartment of Physics, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6397-0002
Emma King-SmithEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2999-0955
Felix A FaberDepartment of Physics, University of Cambridge, Cambridge, UK.
Louise BernierPfizer Research & Development, La Jolla, CA, USA.
Simon BerrittPfizer Research & Development, Groton, CT, USA.ORCID http://orcid.org/0000-0001-5572-6771
William P FarrellPfizer Research & Development, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3341-9831
Xinjun HouPfizer Research & Development, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3473-8455
Jacquelyn L Klug-McLeodPfizer Research & Development, Groton, CT, USA.
Jason MustakisPfizer Research & Development, Groton, CT, USA.ORCID http://orcid.org/0000-0002-8683-0691
Neal W SachPfizer Research & Development, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-9966-7459
Qingyi YangPfizer Research & Development, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5269-0494
Roger M HowardPfizer Research & Development, Groton, CT, USA. Roger.Howard@pfizer.com.ORCID http://orcid.org/0000-0001-5884-4896
Alpha A LeeDepartment of Physics, University of Cambridge, Cambridge, UK. aal44@cam.ac.uk.ORCID http://orcid.org/0000-0002-9616-3108

Funding

RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/X034712/1
6 · The paper itself

Abstract

The efficient separation of chiral molecules is a fundamental challenge in the manufacture of pharmaceuticals and light-polarising materials. We developed an approach that combines machine learning with a physics-based representation to predict resolving agents for chiral molecules, using a transformer-based neural network. In retrospective tests, our approach reaches a four to six-fold improvement over the historical - trial and error based - hit rate. We further validate the model in a prospective experiment, where we use the model to design a resolution screen for six unseen racemates. We successfully resolved three of the six mixtures in a single round of experiments and obtained an overall 8-to-1 true positive to false negative ratio. Together with this study, we release a previously proprietary dataset of over 6000 resolution experiments, the largest diastereomeric salt crystallisation dataset to date. More broadly, our approach and open crystallisation data lay the foundation for accelerating and reducing the costs of chiral resolutions.

Identifiers

PMID40858574
PMCPMC12381160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.